Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kolaja, K. L.
Right arrow Articles by Klaassen, C. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kolaja, K. L.
Right arrow Articles by Klaassen, C. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1998 Oxford University Press

research-article

Dose-Response Examination of UDP-Glucuronosyltransferase Inducers and Their Ability to Increase both TGF-ß Expression and Thyroid Follicular Cell Apoptosis1

Kyle L. Kolaja2 and Curtis D. Klaassen3

Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center Kansas City, Kansas 66160

Received January 7, 1998; accepted May 29, 1998

Exposure to certain microsomal enzyme inducers that increase UDP-glucuronosyltransferase (UDP-GT) activity decreases thyroid hormone levels, which may lead to a subsequent increase in thyroid-stimulating hormone (TSH). This elevation of serum TSH has many effects on the thyroid, including increasing thyroid follicular cell proliferation, leading to hyperplasia. While induction of UDP-GT activity decreases thyroid hormone levels by enhancing biotransformation and subsequent biliary secretion, only certain UDP-GT inducers exhibit the ability to increase serum TSH levels. For example, phenobarbital (PB) and pregnenolone-16{alpha}-carbonitrile (PCN) increase serum levels of TSH, while 3-methylcholanthrene (3MC) and Aroclor 1254 (PCB) do not. Increased serum TSH concentration also enhances thyroid gland expression of TGF-ß1, an anti-proliferative, pro-apoptotic protein. In a previous study in our laboratory, rats were treated for various times (up to 90 days) with PB and PCN, which increased TGF-ß1 protein and apoptosis. The present study was designed to examine the dose-response effect of TSH-increasing (PB and PCN) and nonincreasing (3MC and PCB) UDP-GT inducers on apoptosis and TGF-ß1. PB and PCN, UDP-GT inducing compounds which increase serum TSH, increased the percentage of TGF-ß1-positive follicular cells and increased apoptosis. In contrast, UDP-GT inducers that did not increase TSH (3MC and PCB) did not alter cell death or TGF-ß production. These data suggest that the increase of TGF-ß by TSH may serve to regulate the growth of hyperplastic thyroid.

Key Words: apoptosis; thyroid; phenobarbital (PB); pregnenolone-16{alpha}-carbonitrile (PCN); 3-methylcholanthrene (3-MC); Aroclor 1254 (PCB); and TGF-ß1.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
C. S. Roegge, V. C. Wang, B. E. Powers, A. Y. Klintsova, S. Villareal, W. T. Greenough, and S. L. Schantz
Motor Impairment in Rats Exposed to PCBs and Methylmercury during Early Development
Toxicol. Sci., February 1, 2004; 77(2): 315 - 324.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. T. Zoeller, A. L. S. Dowling, and A. A. Vas
Developmental Exposure to Polychlorinated Biphenyls Exerts Thyroid Hormone-Like Effects on the Expression of RC3/Neurogranin and Myelin Basic Protein Messenger Ribonucleic Acids in the Developing Rat Brain
Endocrinology, January 1, 2000; 141(1): 181 - 189.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.